Dermatology Medical News about Atopic Dermatitis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fluocinolone Acetonide 0.01% in Peanut Oil: Safety and Efficacy Data in the Treatment of Childhood Atopic Dermatitis in Infants as Young as 3 Months of Age
Pediatric Dermatology, 06/26/09

Dohil MA et al. - Results of the study support the safety and efficacy of fluocinolone acetonide 0.01% in refined peanut oil vehicle, for infants as young as 3 months of age with atopic dermatitis. No evidence of adrenal suppression or adverse local effects was demonstrated after 4 weeks of twice daily treatment.

<< Previous
Hypertrophic Scarring is the Usual Outcome of Non-Membranous...

Next >>
Generalized Pustular Psoriasis in a 6-week-old Infant

Topical tacrolimus as treatment of atopic dermatitis
Clinical, Cosmetic and Investigational Dermatology, 11/11/09 Relevance Score: 67%

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09 Relevance Score: 67%

Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis
Pediatric Allergy and Immunology, 10/15/09 Relevance Score: 67%

Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis
Allergy, 10/13/09 Relevance Score: 67%

Structured education program improves the coping with atopic dermatitis in children and their parents--a multicenter, randomized controlled trial
Journal of Psychosomatic Research, 10/09/09 Relevance Score: 67%